Drugs / Human pancreatic islet
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02505893 | Apr 2015 → May 2018 | type 1 diabetes mellitus | Ospedale San Raffaele | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human pancreatic islet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02505893 ↗ |
| Modality | Cell therapy | “allogeneic islet transplantation” PMID 41438972 ↗ Dec 2025 |
| Route | Other | “will be infused into the patient's liver” NCT02505893 ↗ |